JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 1987; 9:263-268
© 1987 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mehta, J
Right arrow Articles by Saldeen, T
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mehta, J
Right arrow Articles by Saldeen, T

Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations

J Mehta, P Mehta, D Lawson, and T Saldeen

Increased levels of an endogenous inhibitor of tissue-plasminogen activator (t-PA) have been thought to relate to the genesis of acute myocardial ischemia. To examine the role of the rapid inhibitor of t-PA, plasma samples were analyzed from 75 patients with chest pain syndrome undergoing coronary angiography (mean age 57 years), 24 patients with clinically documented coronary artery disease (unstable angina, positive exercise stress test or previous history of myocardial infarction; mean age 58 years) and 15 young normal subjects (mean age 26 years). Plasma t-PA inhibitor levels were similar in age-matched patients regardless of the absence or presence (and degree) of coronary artery disease. Plasma t-PA inhibitor levels correlated significantly with age (r - 0.46, p less than 0.005), suggesting an age-dependent decrease in fibrinolytic activity. Plasma t-PA inhibitor levels also correlated significantly with serum triglyceride levels (r - 0.60, p less than 0.001), but not with coronary risk factors such as serum cholesterol, diabetes, hypertension, serum uric acid levels or body weight. Association of high levels of inhibitor of t-PA with hypertriglyceridemia may be of importance in the development of coronary thrombosis, especially in elderly patients. Nonetheless, this study does not suggest a pathogenic role of t-PA inhibitor in coronary atherosclerosis.


This article has been cited by other articles:


Home page
Epidemiol RevHome page
S. Musaad and E. N. Haynes
Biomarkers of Obesity and Subsequent Cardiovascular Events
Epidemiol. Rev., May 10, 2007; (2007) mxm005v1.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
K. A. Meckling, C. O'Sullivan, and D. Saari
Comparison of a Low-Fat Diet to a Low-Carbohydrate Diet on Weight Loss, Body Composition, and Risk Factors for Diabetes and Cardiovascular Disease in Free-Living, Overweight Men and Women
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2717 - 2723.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
K. W. Lee and G. Y. H. Lip
Effects of Lifestyle on Hemostasis, Fibrinolysis, and Platelet Reactivity: A Systematic Review
Arch Intern Med, October 27, 2003; 163(19): 2368 - 2392.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Calles-Escandon and M. Cipolla
Diabetes and Endothelial Dysfunction: A Clinical Perspective
Endocr. Rev., February 1, 2001; 22(1): 36 - 52.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Chen, J. J. Billadello, and D. J. Schneider
Identification and Localization of a Fatty Acid Response Region in the Human Plasminogen Activator Inhibitor-1 Gene
Arterioscler. Thromb. Vasc. Biol., December 1, 2000; 20(12): 2696 - 2701.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. A. Poli, G. H. Tofler, M. G. Larson, J. C. Evans, P. A. Sutherland, I. Lipinska, M. A. Mittleman, J. E. Muller, R. B. D’Agostino, P. W. F. Wilson, et al.
Association of Blood Pressure With Fibrinolytic Potential in the Framingham Offspring Population
Circulation, January 25, 2000; 101(3): 264 - 269.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Banfi, L. Mussoni, P. Rise, M. G. Cattaneo, L. Vicentini, F. Battaini, C. Galli, and E. Tremoli
Very Low Density Lipoprotein–Mediated Signal Transduction and Plasminogen Activator Inhibitor Type 1 in Cultured HepG2 Cells
Circ. Res., July 23, 1999; 85(2): 208 - 217.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Nilsson, C. Banfi, U. Diczfalusy, E. Tremoli, A. Hamsten, and P. Eriksson
Unsaturated Fatty Acids Increase Plasminogen Activator Inhibitor-1 Expression in Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., November 1, 1998; 18(11): 1679 - 1685.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. E. Grenett, R. L. Benza, G. M. Fless, X.-N. Li, G. C. Davis, and F. M. Booyse
Genotype-Specific Transcriptional Regulation of PAI-1 Gene by Insulin, Hypertriglyceridemic VLDL, and Lp(a) in Transfected, Cultured Human Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., November 1, 1998; 18(11): 1803 - 1809.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Geppert, S. Graf, R. Beckmann, S. Hornykewycz, E. Schuster, B. R. Binder, and K. Huber
Concentration of Endogenous tPA Antigen in Coronary Artery Disease : Relation to Thrombotic Events, Aspirin Treatment, Hyperlipidemia, and Multivessel Disease
Arterioscler. Thromb. Vasc. Biol., October 1, 1998; 18(10): 1634 - 1642.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J o. Jeppesen, H. O. Hein, P. Suadicani, and F. Gyntelberg
Triglyceride Concentration and Ischemic Heart Disease : An Eight-Year Follow-up in the Copenhagen Male Study
Circulation, March 24, 1998; 97(11): 1029 - 1036.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. A. B. Sanders, F. R. Oakley, G. J. Miller, K. A. Mitropoulos, D. Crook, and M. F. Oliver
Influence of n-6 versus n-3 Polyunsaturated Fatty Acids in Diets Low in Saturated Fatty Acids on Plasma Lipoproteins and Hemostatic Factors
Arterioscler. Thromb. Vasc. Biol., December 1, 1997; 17(12): 3449 - 3460.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
X.-N. Li, H. E. Grenett, R. L. Benza, S. Demissie, S. L. Brown, E. M. Tabengwa, S. H. Gianturco, W. A. Bradley, G. M. Fless, and F. M. Booyse
Genotype-Specific Transcriptional Regulation of PAI-1 Expression by Hypertriglyceridemic VLDL and Lp(a) in Cultured Human Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3215 - 3223.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. J. Schneider, M. A. Ricci, D. J. Taatjes, P. Q. Baumann, J. C. Reese, B. J. Leavitt, P. M. Absher, and B. E. Sobel
Changes in Arterial Expression of Fibrinolytic System Proteins in Atherogenesis
Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3294 - 3301.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Jeppesen, H. O. Hein, P. Suadicani, and F. Gyntelberg
Relation of High TG–Low HDL Cholesterol and LDL Cholesterol to the Incidence of Ischemic Heart Disease: An 8-Year Follow-up in the Copenhagen Male Study
Arterioscler. Thromb. Vasc. Biol., June 1, 1997; 17(6): 1114 - 1120.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Broijersen, M. Eriksson, B. Wiman, B. Angelin, and P. Hjemdahl
Gemfibrozil Treatment of Combined Hyperlipoproteinemia : No Improvement of Fibrinolysis Despite Marked Reduction of Plasma Triglyceride Levels
Arterioscler. Thromb. Vasc. Biol., April 1, 1996; 16(4): 511 - 516.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Zitoun, L. Bara, A. Basdevant, and M. M. Samama
Levels of Factor VIIc Associated With Decreased Tissue Factor Pathway Inhibitor and Increased Plasminogen Activator Inhibitor-1 in Dyslipidemias
Arterioscler. Thromb. Vasc. Biol., January 1, 1996; 16(1): 77 - 81.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Sironi, L. Mussoni, L. Prati, D. Baldassarre, M. Camera, C. Banfi, and E. Tremoli
Plasminogen Activator Inhibitor Type-1 Synthesis and mRNA Expression in HepG2 Cells Are Regulated by VLDL
Arterioscler. Thromb. Vasc. Biol., January 1, 1996; 16(1): 89 - 96.
[Abstract] [Full Text]


Home page
StrokeHome page
S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso
Predictors of Stroke in Middle-Aged Patients With Non–Insulin-Dependent Diabetes
Stroke, January 1, 1996; 27(1): 63 - 68.
[Abstract] [Full Text]


Home page
ANN INTERN MEDHome page
M. P. Stern
Do Non-Insulin-dependent Diabetes Mellitus and Cardiovascular Disease Share Common Antecedents?
Ann Intern Med, January 1, 1996; 124(1_Part_2): 110 - 116.
[Abstract] [Full Text]


Home page
CirculationHome page
O. C. E. Gebara, M. A. Mittleman, P. Sutherland, I. Lipinska, T. Matheney, P. Xu, F. K. Welty, P. W. F. Wilson, D. Levy, J. E. Muller, et al.
Association Between Increased Estrogen Status and Increased Fibrinolytic Potential in the Framingham Offspring Study
Circulation, April 1, 1995; 91(7): 1952 - 1958.
[Abstract] [Full Text]


Home page
ANGIOLOGYHome page
D. G. Meyers, W. D. Haire, J. K. Rasmussen, and E. J. Boyd
Tissue Plasminogen Activator Release and Plasminogen Activator Inhibitor Levels in Coronary Artery Disease
Angiology, July 1, 1991; 42(7): 561 - 567.
[Abstract] [PDF]


Home page
Vasc MedHome page
A. Hamsten
Myocardial infarction at a young age: mechanisms and management
Vascular Medicine, March 1, 1991; 2(1): 45 - 60.
[PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Yamamoto, K. Takeshita, T. Shimokawa, H. Yi, K.-i. Isobe, D. J. Loskutoff, and H. Saito
Plasminogen activator inhibitor-1 is a major stress-regulated gene: Implications for stress-induced thrombosis in aged individuals
PNAS, January 22, 2002; 99(2): 890 - 895.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1987 by the American College of Cardiology Foundation.